These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22886530)

  • 41. Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.
    Carroll RS; Schrell UM; Zhang J; Dashner K; Nomikos P; Fahlbusch R; Black PM
    Neurosurgery; 1996 Feb; 38(2):367-75. PubMed ID: 8869066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of miRNA-451 and miRNA-885 in Meningiomas.
    Baran O; Karaoglu AC; Kara E; Budun O; Katar S; Yilmaz SG; Akdeniz FT; Ambarcioglu MA; Demirel N; Turk O; Ozdemir NG; Yaltirik CK; Isbir T
    In Vivo; 2023; 37(6):2473-2479. PubMed ID: 37905647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.
    Ding Y; Ge Y; Wang D; Liu Q; Sun S; Hua L; Deng J; Luan S; Cheng H; Xie Q; Gong Y; Zhang T
    Mol Cells; 2022 Jun; 45(6):388-402. PubMed ID: 35680373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
    Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
    Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of several PLA2 mRNA in human meningiomas.
    Denizot Y; De Armas R; Durand K; Robert S; Moreau JJ; Caire F; Weinbreck N; Labrousse F
    Mediators Inflamm; 2009; 2009():689430. PubMed ID: 20339511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.
    Kanno H; Nishihara H; Wang L; Yuzawa S; Kobayashi H; Tsuda M; Kimura T; Tanino M; Terasaka S; Tanaka S
    Neuro Oncol; 2013 Jul; 15(7):853-64. PubMed ID: 23539121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A role for matrix remodelling proteins in invasive and malignant meningiomas.
    Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
    Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J
    Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway.
    Wu Q; Zheng J; Dou C; Qi S
    Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.
    Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y
    Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.
    Fan SY; Jiang JD; Qian J; Lu YC; Hu GH; Luo C; Hou WD; Wang Q
    PLoS One; 2015; 10(5):e0125661. PubMed ID: 25993541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals RB1 Signaling as a Novel Mediator and Biomarker.
    Parada CA; Osbun JW; Busald T; Karasozen Y; Kaur S; Shi M; Barber J; Adidharma W; Cimino PJ; Pan C; Gonzalez-Cuyar LF; Rostomily R; Born DE; Zhang J; Ferreira M
    Clin Cancer Res; 2020 Jan; 26(1):193-205. PubMed ID: 31615938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Expression of MIR17HG Protein as a Potential Therapeutic Target in Meningioma.
    Evran S; Baran O; Kayhan A; Katar S; Akkaya E; Cevik S; Kaya M; Sonmez D; Serin H; Kaynar MY
    World Neurosurg; 2020 May; 137():e554-e563. PubMed ID: 32068173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.
    Curic S; Wu Y; Shan B; Schaaf C; Utpadel D; Lange M; Kuhlen D; Perone MJ; Arzt E; Stalla GK; Renner U
    J Neurooncol; 2013 Jul; 113(3):385-96. PubMed ID: 23666203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meningioma transcription factors link cell lineage with systemic metabolic cues.
    Du Z; Brewster R; Merrill PH; Chmielecki J; Francis J; Aizer A; Abedalthagafi M; Sholl LM; Geffers L; Alexander B; Santagata S
    Neuro Oncol; 2018 Sep; 20(10):1331-1343. PubMed ID: 29660031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.